GlassScriptPhysician profile
Maria V Greier
NPI 1699432922
$531.77
in general payments reported to CMS, 2019-2025
13 companies · $12.50 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $61.78 · 2023: $113 · 2024: $345 · 2025: $12.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $333 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $332.98 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $137.01 | 2024 | Stratafix |
| Revance Therapeutics, INC. | $84.99 | 2024 | Daxxify |
| Mentor Worldwide LLC | $76.43 | 2023-2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Smith+Nephew, INC. | $40.19 | 2023-2024 | Renasys Go V2 Home, Renasys Touch |
| Ethicon US, LLC | $33.62 | 2024 | Stratafix, Dermabond Prineo, Evarrest |
| Kowa Pharmaceuticals America, INC. | $27.42 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $23.98 | 2024 | Exparel |
| Musculoskeletal Transplant Foundation INC. | $22.72 | 2023-2025 | |
| Bioventus LLC | $20.10 | 2023 | Sonicone Clinic |
| Abbvie INC. | $19.38 | 2022 | |
| Xeris Pharmaceuticals, INC. | $17.51 | 2023 | Gvoke Hypopen |
| Currax Pharmaceuticals LLC | $14.98 | 2022 | |
| Dilon Technologies, INC. | $13.44 | 2024 | Hemoblast Bellows |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Greier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.